SANUWAVE Health, Inc. (SNWV)
- Previous Close
31.31 - Open
31.06 - Bid 30.38 x 40000
- Ask 31.00 x 40000
- Day's Range
30.57 - 33.29 - 52 Week Range
25.23 - 39.50 - Volume
28,977 - Avg. Volume
47,959 - Market Cap (intraday)
276.432M - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-6.23 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. It also markets PACE systems that use acoustic pressure shockwaves generated by pulsed acoustic cellular expression technology to converge at selected areas for wound and orthopedic applications under the dermaPACE, Profile, and orthoPACE brand names. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
sanuwave.comRecent News: SNWV
View MorePerformance Overview: SNWV
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SNWV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SNWV
View MoreValuation Measures
Market Cap
276.43M
Enterprise Value
294.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.20
Price/Book (mrq)
--
Enterprise Value/Revenue
8.15
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-96.13%
Return on Assets (ttm)
12.89%
Return on Equity (ttm)
--
Revenue (ttm)
32.63M
Net Income Avi to Common (ttm)
-31.37M
Diluted EPS (ttm)
-6.23
Balance Sheet and Cash Flow
Total Cash (mrq)
10.24M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-13.88M